We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Hypertonic Culture Medium Differentiates Fungal Species

By LabMedica International staff writers
Posted on 11 Apr 2011
A hypertonic glucose agar has been used for phenotypic characterization of two Candida species following molecular classification. More...


Isolates of Candida dubliniensis and C. albicans were distinguished as species by growing them on hypertonic Sabouraud glucose agar (SGA) with 6.5% sodium chloride.

Scientists at the University of Delhi, (Delhi, India), tested the SGA method on 84 isolates of C. albicans, 18 of C. dubliniensis, and 2 reference strains. Of the test C. albicans isolates, 41 originated from the oropharynx of 27 human immunodeficiency virus (HIV) positive patients and the rest from 41 patients with lung diseases. Identity of the test fungi was based on their typical phenotypic characteristics and confirmed by a diagnostic polymerase chain reaction (PCR), that targets the novel C. dubliniensis group I intron in the large ribosomal subunit.

All of the 84 test and 2 reference C. albicans isolates grew on hypertonic SGA, while, in strong contrast, none of the test and reference C. dubliniensis isolates exhibited any growth up to seven days of incubation. Of the 84 C. albicans isolates, 77 (91.6%) inoculated on hypertonic SGA showed growth at 72 hours of incubation and the remaining seven at 96 hours. On Staib agar, 19 of the 20 test C. dubliniensis isolates showed chlamydospore formation at 48 hours of incubation and the solitary remaining isolate at 96 hours. In comparison, most C. albicans isolates did not grow well on this medium. Growth inhibition at 45 °C was observed by all of the test and reference C. dubliniensis isolates. However, growth inhibition also occurred in a large majority of the C. albicans isolates at this temperature indicating poor specificity.

The authors concluded that their observations are highly significant in that hypertonic SGA with 6.5% sodium chloride was entirely free from any false positive or false-negative results. The hypertonic SGA was strongly recommended for wider application as a reliable and inexpensive medium for routine differentiation of C. dubliniensis from C. albicans. The study was published online on March 9, 2011, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:
University of Delhi



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.